Sunday March 21 2010 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
  • A-Z

Pulmonary News and Headlines
Pulmonary News updated every 30 minutes from thousands of internet sites.
Sign-up to BioPortfolio's
Pulmonary news alerts.
Site Map > Biotechnology News > Health News > Pulmonary
.

Azithromycin Alters Macrophage Phenotype and Pulmonary Compartmentalization during Pseudomonas Pneumonia [Article]
AAC:  similar ...
FDA Advisory Committee Recommends Approval Of InterMune's Esbriet(R) (pirfenidone) For Idiopathic Pulmonary Fibrosis
Medical News Today:  similar ...
Medical News: FDA Advisory Committee Recommends Approval Of InterMune's Esbriet(R) (pirfenidone) For Idiopathic Pulmonary Fibrosis
BioFind:  similar ...
Research and Markets: Chronic Obstructive Pulmonary Disease - The Comprehensive Global Strategic Business Report
PR inside:  similar ...
Research and Markets: Chronic Obstructive Pulmonary Disease - The Comprehensive Global Strategic Business Report
Yahoo! Canada:  similar ...
Research and Markets: Chronic Obstructive Pulmonary Disease - The Comprehensive Global Strategic Business Report
Business Wire via Yahoo!:  similar ...
CPF, PFF applaud PF patients' efforts to plead with FDA Advisory Panel regarding lack of treatment options
News-Medical.Net:  similar ...
Pulmonary Fibrosis Patient Organizations Applaud Efforts Of Patients, Families At FDA Hearing
Medical News Today:  similar ...
Medical News: Pulmonary Fibrosis Patient Organizations Applaud Efforts Of Patients, Families At FDA Hearing
BioFind:  similar ...
Reportlinker Adds Global Chronic Obstructive Pulmonary Disease Industry
FOXBusiness.com:  similar ...
Report analyzes worldwide markets for Chronic Obstructive Pulmonary Disease
News-Medical.Net:  similar ...
NeoPharm Announces Orphan Drug Application Filing For IL13-PE38QQR For The Treatment Of Idiopathic Pulmonary Fibrosis
Medical News Today:  similar ...
Medical News: NeoPharm Announces Orphan Drug Application Filing For IL13-PE38QQR For The Treatment Of Idiopathic Pulmonary Fibrosis
BioFind:  similar ...
NeoPharm Announces Orphan Drug Application Filing for IL13-PE38QQR for the Treatment of Idiopathic Pulmonary F
Pharmacy Choice:  similar ...
Pulmonary effects of red blood cell transfusion in critically ill, non-bleeding patients
Transfusion Medicine:  similar ...
FDA Advisory Committee Recommends Approval of InterMune's Esbriet(R) (pirfenidone) for ...
PipelineReview:  similar ...
NeoPharm Announces Orphan Drug Application Filing for IL13-PE38QQR for the Treatment of Idiopathic Pulmonary Fibrosis
Yahoo! Canada:  similar ...
NeoPharm Announces Orphan Drug Application Filing for IL13-PE38QQR for the Treatment of Idiopathic Pulmonary Fibrosis
SmartBrief:  similar ...
NeoPharm Announces Orphan Drug Application Filing for IL13-PE38QQR for the Treatment of Idiopathic Pulmonary F
Pharma Live:  similar ...
FDA Advisory Committee Recommends Approval of InterMune's Esbriet (pirfenidone) for Idiopathic Pulmonary Fibro
Pharma Live:  similar ...

Search BioNews

      --- Advanced searching ---

 

Search BioWeb

      --- Advanced searching ---

 

BioPortfolio updates this list every 30 minutes so please bookmark and revisit regularly during the day:

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright © 1997-2009 - BioPortfolio Limited.